Amicus Therapeutics, Inc. Stock
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 06/05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 29/04 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 4.55B 4B 3.73B 3.42B 6.41B 436B 6.57B 44.25B 17.31B 216B 17.08B 16.71B 746B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.13B 3.85B 3.54B 6.62B 450B 6.78B 45.7B 17.87B 223B 17.64B 17.26B 770B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 6 months | +1.54% | ||
| Current year | +1.76% |
| Current year | 14.2 | 14.5 | |
| 1 year | 5.92 | 14.5 | |
| 3 years | 5.51 | 14.57 | |
| 5 years | 5.51 | 14.57 | |
| 10 years | 4.41 | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 27/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/4/26 | Issuer sale | General Counsel | 1,264,993 | 0.4029% | ||
| 27/4/26 | Issuer sale | Director | 398,261 | 0.1268% | ||
| 27/4/26 | Issuer sale | Director | 395,940 | 0.1261% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.21% | -.--% | +136.38% | +6.78% | 4.55B | ||
| +2.61% | +7.16% | -0.93% | +13.91% | 47.88B | ||
| +1.90% | +24.70% | +27.25% | +9.47% | 40.55B | ||
| -1.60% | -1.15% | +388.84% | +603.70% | 39.09B | ||
| -0.98% | +2.28% | +7.02% | +45.34% | 36.75B | ||
| +1.47% | +5.82% | +5.76% | +43.52% | 27.96B | ||
| -0.94% | +0.05% | - | - | 16.77B | ||
| +2.44% | +10.76% | +30.59% | +129.56% | 15.94B | ||
| -1.14% | +6.52% | -3.80% | -29.33% | 13.81B | ||
| +0.18% | -2.75% | +3.22% | +10.14% | 13.55B | ||
| Average | +0.41% | +4.17% | +66.04% | +92.56% | 25.68B | |
| Weighted average by Cap. | +0.60% | +4.84% | +74.05% | +122.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 464M 433M 398M 744M 50.6B 763M 5.14B 2.01B 25.04B 1.98B 1.94B 86.56B | 634M 557M 520M 477M 894M 60.75B 916M 6.17B 2.41B 30.06B 2.38B 2.33B 104B |
| Net income | -56.11M -49.3M -46.02M -42.23M -79.06M -5.37B -81.01M -546M -213M -2.66B -211M -206M -9.19B | -27.11M -23.82M -22.24M -20.41M -38.2M -2.6B -39.14M -264M -103M -1.28B -102M -99.58M -4.44B |
| Net Debt | 194M 170M 159M 146M 273M 18.55B 280M 1.88B 737M 9.18B 727M 711M 31.74B | 149M 131M 122M 112M 210M 14.26B 215M 1.45B 566M 7.05B 559M 547M 24.39B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions

















